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MicroRNAs are potent modulators of cellular differentiation. miR-145 is expressed in, and promotes the
differentiation of vascular and visceral smooth muscle cells (SMCs). Interestingly, we have observed
that miR-145 also promotes differentiation of the gut epithelium in the developing zebraﬁsh, a cell type
where it is not expressed. Here we identify that a paracrine pathway involving the morphogens Sonic
hedgehog (Shh) in epithelium and bone morphogenic protein 4 (Bmp4) in SMCs is modulated by miR-
145. We show that expression of miR-145 in visceral SMCs normally represses the expression of the
morphogen bmp4, as loss of miR-145 leads to upregulation of bmp4 in SMCs. We show that bmp4 in
turn controls expression of Shh in the visceral epithelium. Conversely, in miR-145 morphants where
bmp4 expression is increased, expression of sonic hedgehog a (shha) is strongly increased in gut
epithelium. We show that expression of bmp4 is modulated by the miR-145 direct target gata6 but not a
second potential direct target, klf5a. Thus although miR-145 is a tissue-restricted microRNA, it plays an
essential role in promoting the patterning of both gut layers during gut development via a paracrine
mechanism.
& 2012 Elsevier Inc. All rights reserved.Introduction
Interactions between epithelial and mesenchymal cells trigger
reciprocal signaling between the two cell types. These interac-
tions are critical during development of organs such as the gut,
ureter, lung, heart, thyroid, liver and pancreas (Lough and Sugi,
2000; Pardo and Selman, 2002; van den Brink, 2007) but also
extend into adulthood in some tissues. Perturbations in epithelial–
mesenchymal interactions are also involved in congenital malforma-
tions and tumor progression (Fromigue et al., 2003; van den Brink,
2007;Wallace et al., 2005). Here we explore howmicroRNA programs
might intersect with epithelial–mesenchymal interactions.
In the intestine, the epithelium sends signals to induce the
differentiation of mesenchyme. Reciprocal signals from the
mesenchyme are essential for epithelial proliferation, morpho-
genesis, and differentiation (van den Brink, 2007). Epithelial–
mesenchymal interactions are largely regulated by secreted
peptides. For instance, Hedgehog (Hh) is expressed in the early
mouse gut endoderm (Bitgood and McMahon, 1995) and has a
paracrine proliferative effect on adjacent mesenchymal progeni-
tors (Mao et al., 2010). Both Shh and Ihh are critical for the radial
patterning of the gut as they regulate villus formation, SMCll rights reserved.differentiation from mesenchymal cells, and development of the
enteric nervous system (Ishizuya-Oka et al., 2006; Liu et al., 2007;
Parkin et al., 2009; Sasaki et al., 2004).
In contrast, bone morphogenetic proteins (BMPs) are secreted
from mesenchymal cells such as the subepithelial ﬁbroblasts in
the Xenopus laevis intestine and the mesenchyme of the embryo-
nic avian gut (Ishizuya-Oka et al., 2006; Roberts et al., 1995;
Sukegawa et al., 2000). BMPs are multi-functional growth factors
that belong to the transforming growth factor b (TGFb) super-
family. Mice deﬁcient for BMP2 and 4 are nonviable due to defects
in cardiac development and failure of mesodermal differentiation,
respectively (Winnier et al., 1995; Zhang and Bradley, 1996).
BMP4 promotes the differentiation of visceral mesenchyme
into SMCs and also facilitates gut maturation through control
of epithelial cell proliferation, differentiation, and migration
(Kedinger et al., 1998; Roberts et al., 1998).
While the genetic control of inductive signals between the
endodermal epithelium and mesenchymal cells of the digestive
tract by morphogens is well characterized (Ishizuya-Oka and
Hasebe, 2008), the regulation of these pathways by speciﬁc
microRNAs (miRNAs/miRs) has not been demonstrated. We
hypothesized that tissue-speciﬁc miRNAs would play critical roles
in regulating digestive tract formation. In particular, we recently
demonstrated that miR-145 is expressed by smooth muscle and
promotes the maturation of visceral smooth muscle of the gut
(Zeng et al., 2009). Furthermore, dysregulation of the microRNAs
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muscle (VSMCs) maturation (Cordes et al., 2009), and vascular
disorders (Cheng et al., 2009; Xin et al., 2009), suggesting it plays
a conserved role in multiple smooth muscle beds. Here we
demonstrate that miR-145 expressed in smooth muscle promotes
gut epithelial differentiation through a paracrine epithelial–
mesenchymal interaction mechanism.Materials and methods
Zebraﬁsh strains and maintenance
Zebraﬁsh (Danio rerio) were maintained and staged according
to standard methods. The wild-type Tu¨bingen Long Fin (TL) strain
was used for all experiments. The sma:GFP promoter used to
make Tg (sma:GFP)ca2 ﬁsh has been described (Zeng et al., 2009).
Morpholino oligonucleotides, miR mimic, and small molecule
inhibition
Morpholinos were obtained from Gene Tools LLC (Corvallis,
OR, USA) and were resuspended in 1 Danieau buffer (Nasevicius
and Ekker, 2000). MiR-145 MO blocks the mature microRNA
(50-TTGCCCAAGGGATTCCTGGGAAAACTGGACC-30), while the
miR-145 control MO (50-CCAAGAACAGTATTTCCAGGAATCC-30)
has a 6-bp mismatch to the miR-145 MO (Zeng et al., 2009).
The Klf5a target protector MO blocks the putative miR-145
binding site (50-CCCAATTTGTCAAACCCAAAAACGC-30). Bmp4
MO (50-GTCTCGACAGAAAATAAAGCATGGG-30) and Gata6 MO
(50-AGCTGTTATCACCCAGGTCCATCCA-30) have been published
(Leung et al., 2005; Peterkin et al., 2003). The Klf5aATG MO was
designed to block translation of klf5a (50-GTAAGAAGCGTAGCGGC-
CATAAACC-30) and Klf5ae3i3 MO blocks splicing of exon 3 to intron
3 (50-TTAATTGCGGAACTCTTACCAGTGT-30). Hsa miR-145 miRI-
DIAN mimic was obtained from Dharmacon (GUCCAGUUUUCC-
CAGGAAUCCCU). Injected doses were: miR-145 MO, 3 ng; miR-
145 Control MO, 3 ng; Bmp4 MO, 12 ng; Klf5aATG MO, 8 ng;
Klf5ae3i3 MO, 8 ng; Gata6 MO, 7.7 ng; miR-145 mimic or control
mimic, 3 ng. The small molecule Dorsomorphin/AMPK inhibitor
(EMD Biochemicals) was administered from 48 to 96 hpf at a ﬁnal
concentration of 50 mm in 0.5% DMSO.
Probe synthesis and in situ hybridization
Digoxigenin (DIG)-labeled antisense RNA probes were gener-
ated for shha (GenBank ID NM_131063), ihha (GenBank ID
NM_001034993), bmp2a (GenBank ID NM_131359), bmp2b (Gen-
Bank ID NM_131360), bmp4 (GenBank ID NM_131342), and klf5a
(GenBank ID CR749750). A T7 polymerase binding site was
incorporated into the 50 end of each reverse primer to generate
antisense probes. Primer sequences are listed in Table S1.
All embryos were ﬁxed in 4% paraformaldehyde in PBS with
0.1% Tween-20 at 4 1C overnight, followed by 100% methanol at
20 1C. In situ hybridization was performed as described (Jowett
and Lettice, 1994) using a Biolane HTI robot (Holle and Huttner
AG, Tubingen, Germany). For microRNA in situ hybridization, a
double-DIG-labeled Locked Nucleic Acid (LNA) probe (Exiqon,
Copenhagen, Denmark) was used to detect the mature miR-145
in whole-mount embryos as recommended by the manufacturer
with the modiﬁcation that hybridization was at 54 1C.
Cell proliferation analysis, immunostaining and feeding assay
Cell proliferation was determined using the Click-iTTM ethynyl
deoxyuridine (EdU) Cell Proliferation Assay Kit (Invitrogen,Burlingame, CA). 72 hours postfertilization (hpf) embryos were incu-
bated in 10mM EdU in E3 medium on ice for 20min prior to transfer
to E3 solution. Embryos were ﬁxed at 96 hpf and permeabilized in 1%
Triton/PBS for 30 min followed by detection of EdU incorporation
as described (Chehrehasa et al., 2009). To determine proliferation,
the EdU positive cell percentage was calculated by dividing the
number of EdU positive cells by total cell number (DAPI) in either
layer.
Phospho-SMAD 1, 5, 8 (pSMAD 1, 5, 8) was detected with
rabbit anti-Phospho-Smad 1 (Ser463/465)/Smad5 (Ser463/465)/
Smad8 (Ser426/428) (1:50; Cell Signaling Technology) using an
antigen retrieval protocol (Akhtar et al., 2009) with the modiﬁca-
tion that 1.8 ug/ml phospholipase A(2) (PLA(2)) was used in
combination with 1.5 ug/ml proteinase K for 20 min after ﬁxation.
GFP in Tg (sma:GFP)ca2 ﬁsh was detected with mouse anti-GFP
antibody, JL8 (1:500, Clontech). Antibody signal was detected
with Alexaﬂuor 555 or 488 secondary antibodies (1:500; Invitro-
gen Molecular Probes), and counterstained with DAPI (Vecta-
shield, Vector Labs). For sections the embryos were embedded in
JB4 (Polysciences) before sectioning at 7 mm sections on a Leica
microtome. Five sections each from 6 embryos were counted.
For feeding assays, embryos were incubated in 0.02% Dextran
tetramethylrhodamine (10,000 MW, Invitrogen, Burlingame, CA)
in E3 medium at 96 hpf until 120 hpf in the dark at 28.5 1C. Live
embryos were visualized as described (Farber et al., 2001).Quantitative real-time PCR (qPCR) analysis
Total RNA from zebraﬁsh embryos was isolated by using the
RNeasy Mini kit (Qiagen). To assay changes in trunk expression
only, the head was removed from embryos using a razor blade
prior to RNA isolation. Three micrograms of total RNA from each
sample were reverse transcribed into cDNA and expression
assayed using the iQ SYBR Green Supermix (Bio-Rad) and a DNA
Engine Opticon 2 system (MJ Research Incorporated). Primer
sequences are listed in Table S1 and expression levels normalized
to that of elongation factor 1a(EF1-a). The DDCt method was used
for calculation of the normalized relative expression level of a
target gene from triplicate measurements.Imaging and statistical analysis
For photography, embryos were embedded in 3% methylcellu-
lose (Sigma) and photographed using a Zeiss Axiocam HRc. An
Optronics Magnaﬁre camera was used to capture images of
sections. Images were processed in Adobe Photoshop CS. For
sectioning, embryos were embedded in JB-4 plastic (Polysciences)
and sectioned at 7 mM on a Leica microtome. Embryos were
photographed on a Leica DMR microscope and transferred into
Adobe Photoshop for ﬁgure assembly. To quantitate ﬂuorescent
signal across the gut for both pSMAD 1, 5, 8 and EdU immunos-
taining, ﬁve sections per ﬁsh were analyzed at different levels of
the gut. Data are expressed as mean7SEM. Three or more
treatment groups were compared by one-way ANOVA followed
by post hoc analysis adjusted with a least signiﬁcant-difference
correction for multiple comparisons (SPSS Inc.). Results were
considered statistically signiﬁcant when po0.05.MicroRNA binding site prediction
The following software packages were used to predict miR-145
binding sites in the 3’ untranslated regions of the bmp4 and klf5a
genes using default settings: DIANA Micro T (Kiriakidou et al., 2004),
RNA22 (Miranda et al., 2006) and RNAfold (Rehmsmeier et al., 2004).
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Loss of miR-145 in smooth muscle leads to defects in gut epithelial
development
Using a double-DIG-labeled LNA in situ hybridization probe with
very sensitive detection of microRNA expression (Jorgensen et al.,
2010) we ﬁnd that miR-145 is expressed robustly in the gut smooth
muscle layer but is not detectable in the gut epithelium (Fig. 1A and
A0) in the 96 hpf zebraﬁsh embryo. Previous expression data using a
single-DIG labeled LNA probe suggested that miR-145 is strongly
expressed in visceral smooth muscle, but also might have weak
staining in the gut epithelium (Zeng et al., 2009). However this
previous weak, spotty expression appears to have been non-speciﬁc
background staining due to low sensitivity of the probe. Thus miR-
145 expression is restricted to smooth-muscle in the gut.
We next show that blocking mature miR-145 function using
the miR-145 morpholino, miR-145 MO (Zeng et al., 2009) results
in strong morphological defects in the gut epithelial layer at
96 hpf, including a decreased diameter and fewer, rounded,
undifferentiated cells in the epithelial lining (Fig. 1C–D). We
tested whether the size reduction of the gut might stem from
defects in cell proliferation since zebraﬁsh gut epithelial cells
show high levels of proliferation between 24 and 96 hpf (Wallace
et al., 2005). Ethynyl deoxyuridine (EdU) was incorporated into
replicating DNA of wild type (WT) and miR-145 MO injected
embryos (n¼15) at 72 hpf. Embryos were then allowed to
develop to 96 hpf before ﬁxation. We found a signiﬁcantly
decreased percentage of proliferative cells in the epithelial layer
in miR-145 morphants (26.077.1%, n¼6; Fig. 1B, D) as opposedFig. 1. Knockdown of smooth muscle expressed miR-145 results in epithelial proliferat
96 hpf shows strong and speciﬁc expression in gut smooth muscle cells (SMC) bu
(B) Quantiﬁcation of the percentage of EDU positive proliferating cells in epithelial an
miR-145 morphant epithelial layer (Po0.01). (C, D) Examples of wild type (WT, C
(B) showing EDU positive cells (red) in the gut epithelium (arrow) but scarce EDU positiv
(blue). (E, F) Lateral view of 120 hpf whole-mount larvae after ingestion of Rhodamine D
in the pharynx of miR-145 morphants (F). The magniﬁcation for C, D is in panel D, anto wild type (44.879.2%, n¼4; p¼0.0065; Fig. 1B and C), but no
change in proliferation of cells in the smooth muscle layer of miR-
145 morphants (7.172.6%, n¼6) as opposed to wild type
(6.272.2%, n¼4; p¼0.56). We note that the smooth muscle
proliferation rate is very low during this period (Fig. 1B).
As digestion begins in the zebraﬁsh larva at 96 hpf, we tested
the functionality of the gut using a rhodamine dextran feeding
assay between 96 and 120 hpf. Wild type embryos showed
ﬂuorescent signal in the pharynx and gut region indicating
movement of the dye through the entire digestive tract
(Fig. 1E). In contrast, rhodamine dextran was only present in
the pharynx but not the gut of miR-145 morphants (Fig. 1F;
n¼12). Lack of dye uptake into the gut could reﬂect morpholo-
gical defects (lack of lumenization of the gut) or functional
deﬁcits (lack of gut motility).
Thus, we ﬁnd that miR-145 is not expressed in the gut
epithelium and yet we observe strong defects in epithelial
differentiation and function after miR-145 knockdown, suggest-
ing that miR-145 indirectly regulates epithelial differentiation.Morphogen expression is upregulated after miR-145 knockdown
The Hh and BMP signaling pathways are known mediators of
epithelial–mesenchymal interactions. We hypothesized that these
morphogens might mediate crosstalk between epithelial and
mesenchymal cells downstream of miR-145. Thus we assayed
expression of bmp 2a, 2b and 4. All three bmps are expressed in the
gut, pharyngeal arches, brain and eye at 96 hpf. Sections through
the gut show that all three bmps are speciﬁcally expressed in theive and functional defects. (A) A transverse section of miR-145 stained embryos at
t not in epithelial cells (EC). (A0) is an enlargement of the boxed area in (A).
d smooth muscle layers (SMC) at 96 hpf shows decreased cell proliferation in the
) and miR-145 morphant (D) transverse sections used for the quantiﬁcation in
e cells in smooth muscle layer (arrowhead). Sections are counterstained with DAPI
extran shows dye in the pharynx (p) and gut (g) of wild type embryos (E), but only
d for E, F is in F.
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layer (bmp4: Fig. 2A–B; bmp2a, 2b: Suppl. Fig. 1A–B, E–F). We next
tested how expression of each of these genes was modulated by miR-
145. Expression of bmp4 is signiﬁcantly increased after miR-145
knockdown (Fig. 2C–D), while expression of bmp 2a or bmp2b does
not change (Suppl. Fig. 1C–D, G–H). qPCR demonstrates a more than
2-fold increase in bmp4 expression in miR-145 morphants as com-
pared to control MO injected embryos (Fig. 2I, po0.01). To investi-
gate whether higher mRNA expression of bmp4 leads to higher
downstream signaling levels we immunostained for phosphorylated
SMAD 1, 5, 8 (pSMAD 1, 5, 8). pSMAD 1, 5, 8 is co-localized with the
gut smooth muscle layer GFP in Tg(asma:GFP) transgenic embryos
and numbers of positive cells signiﬁcantly increased in miR-145
morphants (63.1710.6%, n¼6) as compared to wild type
(21.776.4%, n¼5; po0.0001; Fig. 2J–L). Thus expression of bmp4
is speciﬁcally upregulated in smooth muscle cells of miR-145
morphants, resulting in higher downstream signaling as reﬂected
by increased pSMAD 1, 5, 8 levels.
Since Shh expressed in visceral epithelial cells induces bmp4
in chick, mouse and Xenopus mesenchymal cells, and bmp4
expressed in mesenchymal or smooth muscle cells induces
maturation of the gut epithelium where Shh is expressed, we
hypothesized the same relationship might exist in zebraﬁsh
(Ishizuya-Oka et al., 2006; Mao et al., 2010; Roberts et al., 1995;
Sukegawa et al., 2000). We next investigated whether the Hh
signaling pathway is disrupted in miR-145 morphants. In situ
hybridization shows that both shha and ihha are expressed in the
gut of 96 hpf embryos (shha: Fig. 2E–F, ihha: Suppl. Fig. 1I–J).
Sections in the gut region reveal that shha and ihha are expressed
only in the epithelial layer. A comparison of the expression levelFig. 2. Upregulation of Bmp4 and Shha in the gut of miR-145 morphants. Lateral view
genes have increased expression in miR-145 morphant guts at 96 hpf. Longitudinal sect
and shha (F, H) is expressed in epithelial cells (ec; arrows). The magniﬁcation for B, D, F a
miR-145 leads to strong up-regulation of bmp4 and shha but not the related gene ihh
Increased numbers of pSMAD 1, 5, 8 positive (red; white arrow) smooth muscle cells (g
compared to WT (J), counterstained with DAPI (blue). The scale bar in K represents th
SMCs. Signiﬁcance was determined using the student’s t test (po0.01).of Hh genes in miR-145 control MO injected embryos and miR-
145 MO injected embryos by both in situ hybridization and qPCR
shows a signiﬁcant increase of shha expression (p¼0.011o0.05)
in miR-145 morphants but not in miR-145 control MO injected
embryos, but no change in ihha expression (p¼0.051; shha: Fig. 2
E–I; ihha: Suppl. Fig. 1I–L). Thus shha is speciﬁcally upregulated in
the gut epithelial layer when miR-145 function is blocked.
MiR-145 overexpression decreases shha and bmp4 expression
To test whether upregulation of miR-145 is sufﬁcient to
repress shha and bmp4 expression, we injected a double-stranded
miR-145 RNA mimic into embryos (Zeng et al., 2009). Over-
expression of miR-145 leads to signiﬁcantly decreased expression
of bmp4 (Fig. 3B, F, I; po0.05) and shha (Fig. 3D, H, I; po0.01) in
the gut of 96 hpf embryos as compared to wild type (Fig. 3A, E, C,
G, I), but no change in ihha expression as measured by in situ
hybridization and qPCR (p¼0.23; Fig. 3I; Suppl. Fig. 2E–F0).
Consistent with a speciﬁc effect of miR-145 knockdown on
bmp4 only, miR-145 mimic-injected embryos show no obvious
change in bmp2a and bmp2b expression (Suppl. Fig. 2A–D0). As a
negative control, embryos injected with miR-145 negative control
mimic show no expression changes in any of these genes (Fig. 3I).
Loss of bmp4 phenocopies the effect of miR-145 upregulation
in the gut
In the previous section we showed that miR-145 modulates
bmp4 expression in the mesenchymal/smooth muscle cell layer.
However we noted the upregulation of shha in the epithelial layerof whole-mount in situ expression of bmp4 (A, C) and shha (E, G) shows that both
ions show that bmp4 (B, D) is expressed in smooth muscle cells (smc; arrowheads)
nd H is shown by the scale bar in H. (I) Quantitative PCR shows that knockdown of
a in miR-145 morphants as compared to control embryos (po0.01, n¼3). (J–K)
reen) are found in miR-145 morphants (K) as seen in transverse sections of the gut
e magniﬁcation for J and K. (L) Graph of the proportion of pSMAD 1, 5, 8 positive
Fig. 3. Bmp4 and Shha are downregulated in the gut of miR-145 overexpressing
embryos. Overexpression of miR-145 using a miR-145 mimic leads to decreased
bmp4 as seen in whole-mount (A, B) and longitudinal section (E, F), and to
decreased expression of shha as seen whole-mount (C, D) and in cross section
(G, H). (I) Quantiﬁcation of expression changes in miR-145 mimic shows strong
down-regulation of bmp4 and shha but not ihha levels in miR-145 mimic injected
embryos. Signiﬁcance was determined by a Student’s t-test (po0.01). The scale
bar for A–D is shown in panel D, and the scale bar for E–H is in panel H.
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injected embryos. Thus we hypothesized that bmp4 in the
mesenchymal layer might modulate shh expression in the epithe-
lial layer, and that down-regulation of bmp4 would decrease
expression of shha. Using a translational start site-targeted
morpholino to knock down the expression of bmp4, we ﬁnd that
52% of the morphants display mild pericardial edema, as well as
an unlooped and developmental delayed gut at 96 hpf (Fig. 4A, B).
As a bmp4 morpholino administered at the 1-cell stage of
development might also have indirect effects on gut maturation
we tested the effect of administering a small molecule inhibitor of
bmp signaling (dorsomorphin) after gastrulation. The same phe-
notype is also seen when a small molecule inhibitor of BMP
signaling, dorsomorphin, is applied (Fig. 4C, D). Furthermore,
there is substantial decrease in shha expression speciﬁcally in
the gut in bmp4 morphants and dorsomorphin treated embryos
despite similar levels in the brain (Fig. 4F–I). We note that ihha is
also downregulated in the gut of bmp4 morphants or dorsomor-
phin treated embryos at 96 hpf suggesting that its expression is
also regulated by bmp4 (Fig. 4J–M). qPCR shows that levels of both
shha and ihha are signiﬁcantly decreased in bmp4 morphants and
dorsomorphin treated embryos as compared to wild type unin-
jected controls (Fig. 4E). The reduction in shha and ihha staining
can also be seen in longitudinal section (Fig. 4N–Q). Thus, two
independent lines of evidence suggest that bmp expression
indirectly regulates shh and ihh expression in the gut epithelium.
miR-145 morphants have decreased gut epithelial cell prolif-
eration and increased bmp4 levels. Thus we predicted that
reduction in bmp4 expression (and therefore shh expression)
would lead to increased epithelial proliferation. This was not
the case as we found a signiﬁcant increase in EdU-positive cells in
the smooth muscle layer of bmp4 morphants (31.077.8%, n¼6)
as compared to wild type (17.572.5%, n¼6; p¼0.0024), but no
signiﬁcant increase in EdU counts in the epithelial layer of bmp4morphants (5279.6%, n¼6) as compared to wild type (WT:
46.978.24%, n¼6; p¼0.36; Fig. 4R–T).
Indirect regulation of bmp4 by miR-145
We next sought to identify the direct target of miR-145 that
controls bmp4 expression during these tissue interactions. Using
the target prediction software DIANA MicroTest or RNA22
(Kiriakidou et al., 2004; Miranda et al., 2006) there is no predicted
binding site for miR-145 in the 30UTR of bmp4 suggesting that
miR-145 regulation of bmp4 is indirect. However miR-145 has a
number of experimentally validated targets, of which two are
transcription factors that play a role in gut development, gata6
(Zeng et al., 2009) and klf5a (Xin et al., 2009).
klf5a is a validated target of miR-145 in mouse vascular
smooth muscle (Xin et al., 2009), but not in zebraﬁsh visceral
smooth muscle. We ﬁrst analyzed the expression pattern of klf5a
in zebraﬁsh as it has not been previously reported. klf5a is
expressed ubiquitously at 1 day postfertilization (dpf) and
becomes more restricted to the head area at 2 dpf. At 3 dpf it is
strongly expressed in the gut, while at 4 dpf it is maintained in
the gut and now shows expression in the pharyngeal region
(Fig. 5A–D). In miR-145 morphants klf5a expression is unchanged
in pattern and intensity (Fig. 5E–H). Longitudinal sections
through stained embryos reveals that klf5a is strongly expressed
in the gut epithelium but absent in gut smooth muscle cells
(Fig. 5I). This pattern is unchanged in miR-145 morphants
(Fig. 5J).
We next tested whether the 3’UTR of zebraﬁsh klf5a has a miR-
145 binding site using RNA22 software and ﬁnd that it has a
strong potential site (Fig. 5K). We next examined the phenotype
after klf5a knockdown. Two independent morpholinos directed to
block the translational start (ATG) or a splice-site between exon
3 and intron 3 (e3i3) of klf5a were used to assay its develop-
mental role in zebraﬁsh. Both morpholinos show an identical
phenotype suggesting speciﬁcity of targeting. PCR using primers
ﬂanking the exon targeted by the klf5ae3i3 reveals a reduction of
klf5a transcript in morphants demonstrating the morpholino is
functional (Suppl. Fig. 3E). klf5a morphants display pericardial
edema from 1 to 4 dpf and hydrocephalus in the hind brain
ventricle from 2 to 3 dpf (Klf5aATG MO: Fig. 5L, M; Klf5ae3i3 MO:
Suppl. Fig. 3A–D). Furthermore, the gut is unlooped at 4 dpf,
suggesting it is developmentally delayed. We then designed a
target protector morpholino which binds to the putative miR-145
binding site and protects it from miR-145 binding. Use of this
klf5a TP MO morpholino shows no phenotype when injected into
wild type embryos (Fig. 5N).
If expression changes in bmp4 and shha in miR-145 morphants
are mediated by klf5a, we hypothesize that bmp and hh expres-
sion would be altered in klf5a morphants. However none of bmp4,
shha nor ihha shows signiﬁcant expression changes in either
klf5ae3i3 and Klf5a TP morphant guts as compared to wild type
at 4 dpf by in situ hybridization (Fig. 5O); or by qPCR (Klf5aATG
MO and Klf5a TP MO: Fig. 5P; Klf5ae3i3 MO: Suppl. Fig. 3F). A
caveat of this experiment is that microRNAs can affect protein
translation independently of transcription, but taken together
with our other data, the data in aggregate suggest that even if
klf5a is a target of miR-145, it does not modulate the expression of
shh and bmp4 at this developmental stage.
In contrast, after knockdown of gata6, bmp4, shha and ihha are
strongly down-regulated in the gut of 96 hpf embryos (Fig. 6A–F
(whole-mount), and A0–F0 (section)). qPCR shows signiﬁcantly
decreased levels of bmp4 (0.5 fold, po0.05), shha (0.5 fold,
po0.01) and ihha (0.4 fold, po0.001) expression in gata6
morphants as compared to wild type embryos. We also observe
induction of expression levels of bmp4 (2.6 fold, po0.001), shha
Fig. 4. Knockdown of bmp4 negatively regulates shha expression and promotes SMC proliferation. bmp4 morphants (Bmp4 MO; A, B) and dorsomorphin treated embryos
(C, D) show mild pericardial edema at 96 hpf (B, D) as compared to wild type embryos (A, C). At 96 hpf bmp4 morphants or dorsomorphin treated embryos show an
underdeveloped gut (boxed area, B, D) as compared to wild type embryos (A, C). (E) Loss of Bmp4 leads to strong down-regulation of both shha and ihha at 96 hpf by qPCR
(* refers to po0.05; ** refers to po0.01; n¼3) as compared to wild type. Reduced shha and ihha expression is also seen in bmp4 morphants and dorsomorphin treated
embryos as compared to wild type (F–M). (N–Q) The reduction in staining is also evident in longitudinal section. (R) The percentage of EDU positive smooth muscle and
epithelial cells was quantiﬁed in wild type and bmp4 morphant embryos. There is no signiﬁcant change of the percentage of EdU positive cell in the epithelium, but a
signiﬁcant upregulation of EDU positive smooth muscle cells (SMC). (S,T) Transverse sections of EdU stained cells (red) in the gut of 96 hpf embryos, counterstained with
DAPI (blue). Proliferative SMCs are indicated by arrows. The magniﬁcation for A–D is shown in D, for F–M is in M, for N–Q is in Q, and for S, T is in T.
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protector morphants where the miR-145 binding site is blocked
(Fig. 6G). A rescue of the miR-145 MO phenotype by co-injection
of gata6 MO shows expression levels indistinguishable from wild
type of bmp4 (po0.2), and ihha (po0.3), but not for shha
(po0.02), even though the fold change is 1.1.
We next tested whether gata6 modulates cell proliferation in
the gut. We hypothesized that decreased epithelial proliferation
in miR-145 morphants is caused by an increase in gata6. After
gata6 knockdown, we found a signiﬁcantly increased percentage
of EdU positive cells in the epithelium of gata6 morphants
(68.9721.1%, n¼6) as compared to wild type (46.978.2%,n¼6;
p¼0.039), and increased proliferation of smooth muscle cells of
gata6morphants (36.574.6%, n¼6) as opposed to smooth muscle
cells of wild types (17.572.5%, n¼6; po0.0001; Fig. 6J) at 96 hpf.
Cross sections highlight the immature morphology of the gut of
gata6 morphants (Fig. 6H–I).
Taken together our data suggests that increased expression of
gata6 but not klf5a in miR-145 morphants leads to upregulation of
bmp4, which is critical for the crosstalk between the two gut
layers.Discussion
Paracrine mechanisms play a crucial role in regulating diges-
tive tract development during embryogenesis, particularly
through the Hedgehog and BMP signaling pathways in chickand mouse (Mao et al., 2010; Roberts et al., 1995,1998). However
the roles of microRNAs in regulating crosstalk have not been well
described. We were intrigued to undertake this study by our
observation that knockdown of a smooth muscle speciﬁc micro-
RNA led to strong developmental defects in the adjacent
epithelium.
MiR-145 regulates paracrine signaling through indirect regulation
of BMP4
Our results provide evidence for the pathways through which
miR-145 modulates cross talk during gut development through
regulating paracrine signaling between tissue layers. We pre-
viously demonstrated that gata6 is the direct target of miR-145.
Here we determine that miR-145 indirectly regulates bmp4
expression via gata6. Thus loss of miR-145 leads to an upregula-
tion of Bmp4 signaling. Although there is an abundance of
literature suggesting that Shh in epithelium induces expression
of Bmp in the mesenchymal layer in several species, there are no
clear examples of the reverse induction of Shh by BMP from the
mesenchymal layer. This therefore represents a paracrine loop
promoting maturation of the zebraﬁsh intestine.
The net morphological result of inhibiting miR-145 function is
an immature gut with a reduced number of rounded, poorly
differentiated epithelial cells, and no digestive function. These
defects are due to a gain in expression of both bmp4 and shha
expression, but also possibly to upregulation of other unknown
factors. Thyroid hormones are also known upstream factors that
Fig. 5. klf5a does not modulate bmp4, shha or ihha expression in the gut. (A–H) Whole-mount expression of klf5a. klf5a expression is ubiquitous at 1 dpf (A), restricted to
the head at 2 dpf (B), and is observed in the head and developing gut (arrowheads) at 3 and 4 dpf (C, D). (E–H) Expression of klf5a is unchanged in miR-145 morphants at
the same stages. Compared to wild type embryos at 4 dpf (I), miR-145 morphants (J) show abnormal intestinal epithelial morphology with a lack of a lumen and rounded
cells, but no difference in klf5a expression. Smooth muscle cells are indicated by arrowhead. (K) Folding diagram of the predicted potential miR-145 target site in the
zebraﬁsh klf5a 30UTR. The klf5a 30UTR is in red and the miR-145 mature sequence is indicated in green. (L–N) Phenotype of klf5ae3i3 morphants (M) as compared to klf5a
target protector morphants (klf5aTP MO; N) and wild type embryos (L). klf5ae3i3 morphants show an immature gut (g), lack of swim bladder (sb), pericardial edema and
hemorrhage while klf5a target protector morphants have a normal morphology with the exception of a reduced swim bladder. (O, P) Comparison of bmp4a, shha and ihha
expression in the gut of wild type embryos, klf5ae3i3 morphants and klf5a TP morphants shows no differences by whole-mount in situ staining in the gut region (O), or
quantitative PCR of embryo trunks (P). The magniﬁcation for A–H is shown in A, for I, J is shown in I, for L, M, N is in L, and for O is in the top left panel. All scale bars
represent 100 um.
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patterning process, and may be involved in this regulatory loop
(Ishizuya-Oka and Hasebe, 2008), but their relationship to miR-
145 expression is unknown.
Epithelial and smooth muscle proliferation are differentially
regulated by bmp4 and shha
We observed decreased proliferation in the epithelial layer of
miR-145 morphant guts at a time when cellular proliferation is
high in this layer. These experiments suggest that shh levels are
normally suppressed in order to maintain epithelial proliferation
during early development, and are consistent with the data from
mouse which revealed that Shh restricts epithelial proliferation
via modulation of adjacent mesenchymal cells (Wang et al.,
2002). Interestingly, we do not see a decrease in smooth muscle
proliferation of miR-145 morphants, possibly because smooth
muscle proliferation is very low during this developmental stage.
However, smooth muscle proliferation decreases with increased
BMP4 in other species such as the chick embryo (Roberts et al.,
1998), suggesting that high levels of BMP4 directly or indirectly
repress proliferation of both gut layers. This is consistent with the
idea that Bmp4 serves as a negative regulator of mesodermal
proliferation (Roberts et al., 1995).
In order to isolate the roles of individual genes in the paracrine
pathway we took a knockdown approach. Knockdown of bmp4
leads to a decrease in shha and ihha expression in the epithelial
layer and an increase in smooth muscle proliferation, but not of
epithelial cell proliferation, suggesting that bmp4 functions in acell autonomous manner to control smooth muscle proliferation.
We note that knockdown of bmp4 may not have been complete
using this morpholino, and therefore changes in epithelial pro-
liferation may have been too subtle to observe. In support of this
interpretation, we show that knockdown of gata6 (which in turn
decreases bmp4 levels) leads to an increase in proliferation of
both smooth muscle and epithelial layers. This stronger pheno-
type might indicate that the bmp4 knockdown was incomplete in
bmp4 morphants. Alternatively, gata6 might promote epithelial
proliferation by another mechanism.
MiR-145 is required in the smooth muscle layer
Based on previous data showing strong expression of miR-145
in the visceral smooth muscle and weak spotty expression in the
gut epithelium we previously suggested that miR-145 might act
directly on both cell layers (Zeng et al., 2009). Here a more
sensitive probe clearly shows that miR-145 is only expressed in
smooth muscle, and therefore regulates epithelial development
indirectly. Speciﬁc expression of miR-145 in visceral smooth
muscle is consistent with smooth muscle speciﬁc expression of
miR-145 in mammals (Jorgensen et al., 2010).
Recent data suggests that inactive forms of microRNAs can be
transported by exosomes and function in adjacent tissues
(Simpson et al., 2009). We cannot exclude the possibility that
miR-145 might be secreted from smooth muscle cells to the
epithelium to regulate epithelial cell maturation directly. How-
ever, since we have demonstrated a functional paracrine pathway
involving direct regulation of gata6, and indirect regulation of
Fig. 6. gata6 positively regulates bmp4 and shha expression, and negatively regulates epithelial and smooth muscle proliferation. (A–F): Expression of bmp4, shha and ihha
is decreased in the gut of gata6 morphants at 96 hpf by in situ hybridization (A–F) and qPCR of embryonic trunk (G) as compared to wild type (WT). A0–F0 are longitudinal
sections of stained embryos in the midgut region. (H–I) Transverse sections of the gut show strong EDU staining in both epithelial and smooth muscle layers in WT
embryos (H) and gata6morphants (I) at 96 hpf. (J) Quantiﬁcation of EdU positive epithelial and smooth muscle cells shows signiﬁcantly increased proliferative cells in both
layers of the gata6 morphant gut. (* indicates po0.05; ** indicates po0.01). (K) Model for miR-145 regulation of visceral paracrine pathways. The visceral smooth muscle
cells (SMCs) are shown in light blue and the gut epithelium in dark green. In wild type embryos, Hedgehog family members are expressed in the epithelium and
responsible for the induction of the bmp4 in the adjacent smooth muscle layers. MiR-145 normally inhibits expression of gata6, maintaining low bmp4 expression levels in
smooth muscle cells. When miR-145 is downregulated, gata6 expression increases, promotes bmp4 expression, and via paracrine secretion, activates higher expression of
both shh and ihh in the epithelial layer in a positive feedback loop, leading to decrease proliferation of both layers. The magniﬁcation for A–F is shown in F, for A0–F0 is
shown in F0 and for H, I is shown in I.
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secretion of miR-145 is necessary to this process.
Gata6 but not Klf5a is a functional target of miR-145 modulating
cross talk
MicroRNAs recognize targets through an 8 base pair seed
sequence in addition to a number of matches outside the seed
region. Target prediction of microRNAs is difﬁcult due to the large
number of potential binding sites, and computer algorithms
typically predict far more targets than can be experimentally
validated. Recent deep sequencing of mRNAs associated with
Argo2 in conjunction with overexpression of individual micro-
RNAs suggests that microRNAs associate with roughly 100–400
target mRNAs (Hendrickson et al., 2008; Matkovich et al., 2011),
although this type of analysis has not yet been performed for
miR-145. Using the available data for miR-145 targets, we took
the approach of investigating two previously experimentally
validated targets, gata6 and klf5a that showed strong expression
in the developing zebraﬁsh gut (Xin et al., 2009; Zeng et al., 2009).
We have previously demonstrated that gata6 is an important
target of miR-145 in the context of gut smooth muscle development,
as knockdown of gata6 can rescue miR-145 morphant phenotype
(Zeng et al., 2009). However, it remained possible that other miR-145
target genes might also affect visceral smooth muscle development.Klf5a is a zinc ﬁnger transcription factor involved in vascular smooth
muscle phenotypic switching and a direct miR-145 target in mouse
carotid arteries (Suzuki et al., 2009; Xin et al., 2009). However
whether this interaction between klf5a and miR-145 also exists in
visceral smooth muscle during the development of zebraﬁsh gut was
unknown. We have for the ﬁrst time provided detailed expression
pattern and functional analysis of klf5a during zebraﬁsh gut devel-
opment. A conserved miR-145 binding site was found in the 30UTR of
zebraﬁsh klf5a and knockdown resulted in heart and gut develop-
mental defects. However several lines of evidence suggest that klf5a
is not a target of miR-145 in the context of regulation of this
epithelial–mesenchymal bmp4-shh paracrine pathway in the zebra-
ﬁsh gut. First, klf5a is expressed in the epithelial layer, but not in
smooth muscle, suggesting it cannot be a direct target of miR-145 at
this developmental stage. This is consistent with ﬁndings in mice
which shows strong klf5a mRNA signal in the basal level of the
epidermis and intestinal crypts at E17.5 (Ohnishi et al., 2000).
Second, klf5a expression is unchanged after miR-145 knockdown.
Thirdly, bmp4 and shha show similar expression level after klf5a
knockdown. Fourthly, injection of a target protector morpholino
shows no effect on gene expression of bmp4, shha or ihha. Thus, it
therefore appears unlikely that klf5a functions as a direct miR-145
target in early zebraﬁsh smooth muscle development.
On the other hand, gata6 is expressed with the correct
spatiotemporal expression pattern to interact directly with
L. Zeng, S.J. Childs / Developmental Biology 367 (2012) 178–186186miR-145 in smooth muscle. Importantly, expression of gata6 is
similar to that of bmp4, and gata6 is a transcriptional activator of
bmp4 in vitro (Nemer and Nemer, 2003). Furthermore we ﬁnd
decreased expression of bmp4 in gata6 morphants. At the cellular
level, decreased proliferation of epithelial cells in miR-145 mor-
phants correlates with overexpression of gata6 in smooth muscle
cells. This is consistent with data demonstrating that Gata6 stops
the proliferation of vascular smooth muscle in vitro (Perlman
et al., 1998) and reduced myocyte proliferation in Gata4/6 mutant
mice in vivo (Xin et al., 2006). Taken together, these observations
support gata6 is a bona ﬁde target of miR-145 and modulates
paracrine signaling in the gut (Fig. 6K).
To summarize, our study speciﬁcally addresses the regulation
of the bmp4-shha signaling pathway by miR-145, and demon-
strates that gata6 is an intermediate direct target. This study
provides the ﬁrst insights into the miRNA involvement in the
patterning of the gut tissue during development.Acknowledgments
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